Neurotrope News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.09.19	5 Top Losers In Healthcare Sector (NTRP, AKRO, SAVA...) (RTTNews)
14.08.19	5 Top Losers In Healthcare Sector (RMED, NMRD, NTRP…) (RTTNews)
05.08.19	Neurotrope's Alzheimer's Trial Data: Mark Your Calendar (RTTNews)
14.12.18	ADIL Leaps, HIIQ Settles With Insurance Regulators, KZR Hits New High (RTTNews)
07.05.18	Neurotrope, In Consultation With Leading Neuroscientists, Completes the Study Design for its Confirmatory Phase 2 Trial in Advanced Alzheimer's Patients (PR Newswire)
25.04.18	Spark451 Launches Element451 to Transform Enrollment Management (PR Newswire)
28.02.18	Neurotrope to Present at the Cowen and Company 38th Annual Health Care Conference (PR Newswire)
07.02.18	Neurotrope to Present at BIO CEO & Investor Conference (PR Newswire)
25.01.18	Neurotrope to Present at NobleCon 14th Annual Institutional Investor Conference (PR Newswire)
05.01.18	Neurotrope's Bryostatin Improves Cognition in Patients with Advanced Alzheimer's Disease Based on Further Analysis of Phase 2 Clinical Trial Data (PR Newswire)
19.12.17	Neurotrope to Present Additional Findings from Bryostatin Phase 2 Trial in Advanced Alzheimer's Disease (PR Newswire)
18.12.17	Neurotrope Appoints Charles S. Ryan as Chief Executive Officer (PR Newswire)
28.09.17	Princess Cruises Wilderness Treehouse Unveiled in Finale Episode Of Animal Planet's "Treehouse Masters" (PR Newswire)
09.08.17	Neurotrope Provides Business Update and Reports Second Quarter 2017 Financial Results (PR Newswire)
20.07.17	Gainers & Losers Of July 19: AEZS, VRTX, AGRX, PTI, INO... (RTTNews)
19.07.17	Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017 (PR Newswire)
19.07.17	Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 2017 (PR Newswire)
14.07.17	Rosen Law Firm Reminds Neurotrope, Inc. Investors of Important July 17 Deadline in Class Action - NTRP (PR Newswire)
05.07.17	EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Neurotrope, Inc. - NTRP (PR Newswire)
29.06.17	Neurotrope to Present Bryostatin Phase 2 Data in an Oral Presentation at AAIC 2017 Meeting (PR Newswire)
16.06.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Neurotrope, Inc. of Class Action Lawsuit and Upcoming Deadline - NTRP (PR Newswire)
01.06.17	URGENT: Monteverde & Associates PC Invites Neurotrope, Inc. Shareholders with Losses To Contact The Firm Immediately - NTRP (PR Newswire)
30.05.17	Lifshitz & Miller LLP Announces Investigation of AirMedia Group Inc., Forterra, Inc., Neurotrope, Inc., Orbotech Ltd., Sinovac Biotech Ltd., SunPower Corporation and United Technologies Corporation (PR Newswire)
30.05.17	IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Neurotrope, Inc. and Encourages Investors with Losses to Contact the Firm (PR Newswire)
22.05.17	LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Neurotrope, Inc. To Contact The Firm (PR Newswire)
19.05.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Neurotrope, Inc. (NTRP) and Lead Plaintiff Deadline - July 17, 2017 (PR Newswire)
02.05.17	Gainers & Losers Of May 1: VTGN, VSTM, TOCA, NTRP, AEZS... (RTTNews)
01.05.17	MÄRKTE USA/Wall Street uneinheitlich - Apple auf Allzeithoch (Dow Jones)
01.05.17	MÄRKTE USA/Wall Street nach Budgetkompromiss uneinheitlich (Dow Jones)
28.04.17	Neurotrope Bioscience to Release Results From Phase 2 Clinical Trial in Moderate to Severe Alzheimer's Disease on May 1, 2017 (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Neurotrope Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten